The following tables summarize the components of the basic and diluted EPS computations (in thousands, except per share amounts):


	Three Months Ended June 30,					Six Months Ended June 30,
	2026			2025		2026			2025
EPS – basic:
Net (loss) income (numerator)	$	(19,032	)	$	668	$	(35,651	)	$	13,826
Weighted average common shares (denominator)		309,191			304,954		308,732			304,222
Net (loss) income per share	$	(0.06	)	$	0.00	$	(0.12	)	$	0.05
EPS – diluted:
Net (loss) income (numerator)		(19,032	)		668		(35,651	)		13,826
Weighted average common shares		309,191			304,954		308,732			304,222
Effect of dilutive securities – common shares issuable		—			6,530		—			8,159
Adjusted weighted average common shares (denominator)		309,191			311,484		308,732			312,381
Net (loss) income per share	$	(0.06	)	$	0.00	$	(0.12	)	$	0.04

For the three months ended June 30, 2026, diluted net loss per share was the same as basic net loss per share because the inclusion of potential common shares would have been antidilutive. Potentially dilutive securities outstanding for the three months ended June 30, 2026 were 20.3 million shares of common stock underlying RSUs and Market RSUs and 11.6 million shares underlying options.

For the six months ended June 30, 2026, diluted net loss per share was the same as basic net loss per share because the inclusion of potential common shares would have been antidilutive. Potentially dilutive securities outstanding for the six months ended June 30, 2026 were 10.3 million shares of common stock underlying RSUs and Market RSUs and 3.1 million shares underlying options.

For the three months ended June 30, 2025, diluted net income per share excluded the weighted average effect of 6.3 million shares of common stock underlying RSUs and Market RSUs, 1.0 million shares underlying options, and 7.0 million common shares issuable upon conversion of our senior convertible notes as they were antidilutive.

For the six months ended June 30, 2025, diluted net income per share excluded the weighted average effect of 3.3 million shares of common stock underlying RSUs and Market RSUs, 0.3 million shares underlying options, and 7.0 million common shares issuable upon conversion of our senior convertible notes as they were antidilutive.